Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth‐POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries

Head & Neck ◽  
2020 ◽  
Vol 42 (10) ◽  
pp. 2968-2974
Author(s):  
Nupur Karan ◽  
Suhail Siddiqui ◽  
Kailash S. Sharma ◽  
Gouri H. Pantvaidya ◽  
Jigeeshu V. Divatia ◽  
...  
Nanomaterials ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. 1938
Author(s):  
Jefferson Muniz de Lima ◽  
Paulo Rogerio Bonan ◽  
Danyel Elias da Cruz Perez ◽  
Michael Hier ◽  
Moulay A. Alaoui-Jamali ◽  
...  

Head and neck cancer (HNC) is a complex and heterogeneous disease associated with high mortality and morbidity worldwide. Standard therapeutic management of advanced HNC, which is based on radiotherapy often combined with chemotherapy, has been hampered by severe long-term side effects. To overcome these side effects, tumor-selective nanoparticles have been exploited as a potential drug delivery system to improve HNC therapy. A combination of MEDLINE, EMBASE, Cochrane Oral Health Group’s Trials Register, Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov from inception up to June 2020 was used for this systematic review. A total of 1747 published manuscripts were reviewed and nine relevant references were retrieved for analysis, while eight of them were eligible for meta-analysis. Based on these studies, the level of evidence about the efficacy of nanoformulation for HNC therapy on tumor response and adverse side effects (SAE) was low. Even though basic research studies have revealed a greater promise of nanomaterial to improve the outcome of cancer therapy, none of them were translated into clinical benefits for HNC patients. This systematic review summarized and discussed the recent progress in the development of targeted nanoparticle approaches for HNC management, and open-up new avenues for future perspectives.


Cancer ◽  
1991 ◽  
Vol 67 (3) ◽  
pp. 716-721 ◽  
Author(s):  
Maha Hussain ◽  
Julie A. Kish ◽  
Lawrence Crane ◽  
Ahmed Uwayda ◽  
Glen Cummings ◽  
...  

2011 ◽  
Vol 126 (2) ◽  
pp. 111-115 ◽  
Author(s):  
J Rimmer ◽  
C E B Giddings ◽  
F Vaz ◽  
J Brooks ◽  
C Hopper

AbstractBackground:Major vascular complications in patients with head and neck cancer have previously been thought of as terminal events. However, it is now possible to intervene in many situations, with benefits for quality of life as well as survival. Endovascular techniques have reduced morbidity and mortality in many situations, both emergency and elective.Method:We describe the techniques that can be employed in such situations, and present illustrative case reports. Life-threatening haemorrhage, carotid compression and radiation-induced carotid stenosis are all discussed.Conclusion:It is possible to predict where complications may arise, and to take prophylactic steps to allow treatment to continue. Early intervention can reduce both morbidity and mortality in this high-risk patient group.


1980 ◽  
Vol 88 (6) ◽  
pp. 695-699 ◽  
Author(s):  
Matthew J. Lambert

Malnutrition is a common problem in patients with head and neck cancer. Its presence may lead to an increase in morbidity and mortality following an operation, chemotherapy, and radiation therapy. A standard nutritional assessment will define the nature and degree of the nutritional deficiency while periodic reassessment will document the effects of nutritional support.


2017 ◽  
Vol 128 (4) ◽  
pp. 871-877 ◽  
Author(s):  
Heidi E. L'Esperance ◽  
Dorina Kallogjeri ◽  
Shahnawaz Yousaf ◽  
Jay F. Piccirillo ◽  
Jason T. Rich

2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P69-P69
Author(s):  
Stephen Y. Lai ◽  
Richa Rashmi ◽  
Carol M. Lewis ◽  
Amy C. Hessel ◽  
Paul W. Gidley ◽  
...  

1996 ◽  
Vol 17 (5) ◽  
pp. 308-310 ◽  
Author(s):  
Jeffrey R. Haller ◽  
Rodney E. Mountain ◽  
David E. Schuller ◽  
Subir Nag

Sign in / Sign up

Export Citation Format

Share Document